Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1964 Sep 19;2(5411):730–732. doi: 10.1136/bmj.2.5411.730

Phenindione Sensitivity

Arthur Hollman, H O Wong
PMCID: PMC1815835  PMID: 14172038

Full text

PDF
730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS C. W., PASS B. J. Extensive dermatitis due to warfarin sodium (coumadin). Circulation. 1960 Nov;22:947–948. doi: 10.1161/01.cir.22.5.947. [DOI] [PubMed] [Google Scholar]
  2. AGER J. A., INGRAM G. I. Agranulocytosis during phenindione therapy. Br Med J. 1957 May 11;1(5027):1102–1103. doi: 10.1136/bmj.1.5027.1102-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BAKER S. B., WILLIAMS R. T. Acute interstitial nephritis due to drug sensitivity. Br Med J. 1963 Jun 22;1(5346):1655–1658. doi: 10.1136/bmj.1.5346.1678-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BARRITT D. W., JORDAN S. C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960 Jun 18;1(7138):1309–1312. doi: 10.1016/s0140-6736(60)92299-6. [DOI] [PubMed] [Google Scholar]
  5. BINGLE J., SHINE I. Phenindione sensitivity. Lancet. 1959 Sep 19;2(7099):377–378. doi: 10.1016/s0140-6736(59)91640-x. [DOI] [PubMed] [Google Scholar]
  6. BROOKS R. H., CALLEJA H. B. Dermattis, hepatitis and nephritis due to phenindione (phenylindandione). Ann Intern Med. 1960 Mar;52:706–710. doi: 10.7326/0003-4819-52-3-706. [DOI] [PubMed] [Google Scholar]
  7. BROWN K. W., MACMILLAN R. L. The choice of an anticoagulant. Am J Med Sci. 1954 May;227(5):526–529. doi: 10.1097/00000441-195405000-00006. [DOI] [PubMed] [Google Scholar]
  8. BURNS C., DESMOND F. B. Sensitivity to dindevan (phenylindanedione) report of a case with review of the literature. N Z Med J. 1958 Jun;57(319):283–291. [PubMed] [Google Scholar]
  9. CLATANOFF D. V., MEYER O. O. Further observations on use of warfarin sodium in anticoagulant therapy. AMA Arch Intern Med. 1956 Jun;97(6):753–757. doi: 10.1001/archinte.1956.00250240105009. [DOI] [PubMed] [Google Scholar]
  10. COON W. W., DUFF I. F., HODGSON P. E., DENNIS E. W. Therapeutic evaluation of a new anticoagulant, phenylindandione. Ann Surg. 1953 Sep;138(3):467–475. doi: 10.1097/00000658-195309000-00019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. DEMING J. W. Toxic reaction to phenindione. J La State Med Soc. 1960 Dec;112:463–465. [PubMed] [Google Scholar]
  12. EAST E. N., BEAMISH R. E. Severe sensitivity reaction (hepatitis, dermatitis and pyrexia) attributable to phenylindanedione. Can Med Assoc J. 1957 Dec 1;77(11):1028–1030. [PMC free article] [PubMed] [Google Scholar]
  13. FEDER W., AUERBACH R. "Purple toes": an uncommon sequela of oral coumarin drug therapy. Ann Intern Med. 1961 Dec;55:911–917. doi: 10.7326/0003-4819-55-6-911. [DOI] [PubMed] [Google Scholar]
  14. GALEA E. G., YOUNG L. N., BELL J. R. Fatal nephropathy due to phenindione sensitivity. Lancet. 1963 Apr 27;1(7287):920–922. doi: 10.1016/s0140-6736(63)91693-3. [DOI] [PubMed] [Google Scholar]
  15. JOHNMAN L. Sensitivity to phenindione: report of a case. Scott Med J. 1957 Aug;2(8):330–331. doi: 10.1177/003693305700200805. [DOI] [PubMed] [Google Scholar]
  16. JONES N. L. Hepatitis due to phenindione sensitivity. Br Med J. 1960 Aug 13;2(5197):504–506. doi: 10.1136/bmj.2.5197.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. JUEL-JENSEN B. E. Sensitivity to phenindione: report of a case of severe diarrhoea. Br Med J. 1959 Aug 15;2(5145):173–174. doi: 10.1136/bmj.2.5145.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KERRIN H. F., GUIDOT J., WILHELM S. K. Clinical experiences with the anticoagulant coumadin (warfarin) sodium. Angiology. 1957 Jun;8(3):302–307. doi: 10.1177/000331975700800308. [DOI] [PubMed] [Google Scholar]
  19. KIPEN C. S. Gangrane of the breast--a complication of anticoagulant therapy. Report of two cases. N Engl J Med. 1961 Sep 28;265:638–640. doi: 10.1056/NEJM196109282651307. [DOI] [PubMed] [Google Scholar]
  20. LANGLEY R. B., McCREDIE K. B. Sensitivity to phenindione. N Z Med J. 1963 May;62:243–244. [PubMed] [Google Scholar]
  21. MATHER G., RILEY C. Idiosyncrasy to phenindione. Br Med J. 1960 Aug 13;2(5197):506–507. doi: 10.1136/bmj.2.5197.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. O'REILLY R. A., AGGELER P. M., LEONG L. S. STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN. J Clin Invest. 1963 Oct;42:1542–1551. doi: 10.1172/JCI104839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. PASTOR B. H., TETREAULT A. F. Agranulocytosis and scarlatiniform eruption due to phenindione. J Am Med Assoc. 1956 Jun 30;161(9):873–874. doi: 10.1001/jama.1956.62970090014017f. [DOI] [PubMed] [Google Scholar]
  24. PEARCE J. M. Nephropathy and phenindione sensitivity. Lancet. 1963 May 25;1(7291):1158–1159. doi: 10.1016/s0140-6736(63)91832-4. [DOI] [PubMed] [Google Scholar]
  25. PERKINS J. Phenindione jaundice. Lancet. 1962 Jan 20;1(7221):125–127. doi: 10.1016/s0140-6736(62)91130-3. [DOI] [PubMed] [Google Scholar]
  27. PORTAL R. W., EMANUEL R. W. Phenindione hepatitis complicating anticoagulant therapy. Br Med J. 1961 Nov 18;2(5263):1318–1319. doi: 10.1136/bmj.2.5263.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. RODMAN T., RYAN C. S., PASTOR B. H., HOLLENDONNER W. J. A comparative study of four prothrombinopenic anticoagulant drugs. II. Clinical study. Am J Med. 1959 Sep;27:415–423. doi: 10.1016/0002-9343(59)90007-5. [DOI] [PubMed] [Google Scholar]
  29. SHEPS S. G., GIFFORD R. W., Jr Urticaria after administration of warfarin sodium. Am J Cardiol. 1959 Jan;3(1):118–120. doi: 10.1016/0002-9149(59)90403-5. [DOI] [PubMed] [Google Scholar]
  30. SMITH P. C. Fatal agranulocytosis due to phenylindanedione: report of a case. Ann Intern Med. 1959 Sep;51:617–620. doi: 10.7326/0003-4819-51-3-617. [DOI] [PubMed] [Google Scholar]
  31. TASHJIAN A. H., Jr, LEDDY J. P. Agranulocytosis associated with phenindione: a case report with review of the literature. Arch Intern Med. 1960 Jan;105:121–125. doi: 10.1001/archinte.1960.00270130137018. [DOI] [PubMed] [Google Scholar]
  32. TOOHEY M. Clinical experience with warfarin sodium. Br Med J. 1958 Oct 11;2(5101):892–893. doi: 10.1136/bmj.2.5101.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. TOWNSEND S. R., FAY K. J., DOWNING J. R., LAING R., CAMERON D. G. Phenylindanedione: a useful anticoagulant. Can Med Assoc J. 1953 Aug;69(2):149–151. [PMC free article] [PubMed] [Google Scholar]
  34. WALLACE D. C. Sensitivity to phenindione ("dindevan"): report of two cases. Med J Aust. 1960 Jun 11;47(1):934–936. doi: 10.5694/j.1326-5377.1960.tb78448.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES